Global Anticancer Drug Market Estimated to Reach USD 172.52 Billion in 2023 with Continued Growth Projected Through 2029
April 03, 2024 11:51 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Global Cytotoxic Drugs Market Report 2023: Players Include Bristol-Myers Squibb, Novartis, Pfizer, Merck & Co and Amgen
May 22, 2023 11:23 ET
|
Research and Markets
Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Global Cytotoxic Drugs Market Size, Trends, By Route of Administration, By Drug Type, By Application, and By Region: Global Opportunity Analysis and...
Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market
May 16, 2023 09:58 ET
|
Sunshine Biopharma Inc.
MONTREAL, May 16, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
May 11, 2023 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Worldwide Pet Cancer Therapeutics Industry to 2027: Increasing Awareness Regarding Pet Healthcare and Treatments Drives Growth
February 24, 2023 07:23 ET
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Pet Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Therapy (Surgery, Radiotherapy,...
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
February 10, 2023 07:35 ET
|
Sunshine Biopharma Inc.
MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma Announces Share Repurchase Program
January 19, 2023 07:30 ET
|
Sunshine Biopharma Inc.
MONTREAL, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma’s Annual Letter to Shareholders
December 20, 2022 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
October 20, 2022 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Epirubicin Market Worth $243.99 Million, Globally, by 2028 at 3.6% CAGR - Exclusive Report by The Insight Partners
July 22, 2022 06:56 ET
|
The Insight Partners
New York, July 22, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage (10mg/Vial,...